| Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral … M Samant, R Gupta, S Kumari, P Misra, P Khare, PK Kushawaha, ... The Journal of Immunology 183 (1), 470-479, 2009 | 90 | 2009 |
| Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects … PK Kushawaha, R Gupta, S Sundar, AA Sahasrabuddhe, A Dube The Journal of Immunology 187 (12), 6417-6427, 2011 | 86 | 2011 |
| Antileishmanial activity mediated by apoptosis and structure-based target study of peganine hydrochloride dihydrate: an approach for rational drug design P Misra, T Khaliq, A Dixit, S SenGupta, M Samant, S Kumari, A Kumar, ... Journal of antimicrobial chemotherapy 62 (5), 998-1002, 2008 | 65 | 2008 |
| Characterization of glycolytic enzymes-rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic … R Gupta, V Kumar, PK Kushawaha, CP Tripathi, S Joshi, ... Plos one 9 (1), e86073, 2014 | 58 | 2014 |
| Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral Leishmaniasis PK Kushawaha, R Gupta, CDP Tripathi, S Sundar, A Dube PLoS One 7 (4), e35670, 2012 | 47 | 2012 |
| Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite … R Gupta, PK Kushawaha, M Samant, AK Jaiswal, RK Baharia, A Dube Journal of antimicrobial chemotherapy 67 (2), 440-443, 2012 | 46 | 2012 |
| Leishmania donovani Triose Phosphate Isomerase: A Potential Vaccine Target against Visceral Leishmaniasis PK Kushawaha, R Gupta, CDP Tripathi, P Khare, AK Jaiswal, S Sundar, ... Public Library of Science 7 (9), e45766, 2012 | 38 | 2012 |
| Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation … AK Jaiswal, P Khare, S Joshi, PK Kushawaha, S Sundar, A Dube PLoS One 9 (9), e108556, 2014 | 29 | 2014 |
| A novel recombinant Leishmania donovani p45, a partial coding region of methionine aminopeptidase, generates protective immunity by inducing a Th1 stimulatory response against … R Gupta, PK Kushawaha, CDP Tripathi, S Sundar, A Dube International journal for parasitology 42 (5), 429-435, 2012 | 29 | 2012 |
| Withania somnifera chemotype NMITLI 101R significantly increases the efficacy of antileishmanial drugs by generating strong IFN-γ and IL-12 mediated immune responses in … CDP Tripathi, PK Kushawaha, RS Sangwan, C Mandal, ... Phytomedicine 24, 87-95, 2017 | 22 | 2017 |
| Comparative analysis of cellular immune responses in treated Leishmania patients and hamsters against recombinant Th1 stimulatory proteins of Leishmania donovani S Joshi, NK Yadav, K Rawat, CDP Tripathi, AK Jaiswal, P Khare, ... Frontiers in Microbiology 7, 312, 2016 | 18 | 2016 |
| Efficacy of Withania somnifera chemotypes NMITLI – 101R, 118R and Withaferin A against experimental visceral leishmaniasis CDP Tripathi, R Gupta, PK Kushawaha, C Mandal, S Misra Bhattacharya, ... Parasite Immunology 36 (6), 253-265, 2014 | 12 | 2014 |
| Chandipura virus utilizes the prosurvival function of RelA NF-κB for its propagation SS Bais, Y Ratra, NA Khan, R Pandey, PK Kushawaha, S Tomar, ... Journal of virology 93 (14), 10.1128/jvi. 00081-19, 2019 | 9 | 2019 |
| Staphylococcus aureus vaccine strategy: promise and challenges U Chand, P Priyambada, PK Kushawaha Microbiological Research, 127362, 2023 | 8 | 2023 |
| Leishmania donovani secretory protein nucleoside diphosphate kinase b localizes in its nucleus and prevents ATP mediated cytolysis of macrophages PK Kushawaha, CDP Tripathi, A Dube Microbial pathogenesis 166, 105457, 2022 | 4 | 2022 |
| Transferrin decorated PLGA encumbered moxifloxacin nanoparticles and in vitro cellular studies GA Reddy, M Handa, D Garabadu, R Kumar, PK Kushawaha, R Shukla Drug Development and Industrial Pharmacy 49 (1), 129-138, 2023 | 3 | 2023 |
| Postbiotics: an alternative and innovative intervention for the therapy of inflammatory bowel disease H Om, U Chand, PK Kushawaha Microbiological Research, 127550, 2023 | 2 | 2023 |
| Interferon inducible guanylate binding protein 1 restricts the growth of Leishmania donovani by modulating the level of cytokines/chemokines and MAP kinases R Kumar, PK Kushawaha Microbial Pathogenesis 168, 105568, 2022 | 2 | 2022 |
| Update on monkeypox virus infection: Focusing current treatment and prevention approaches R Dhapola, S Kumari, P Sharma, P KumarKushawaha, ... Fundamental & Clinical Pharmacology, 2024 | 1 | 2024 |
| Bilayer fixed-dose combination tablet for curcumin microparticles and piroxicam and in vitro evaluation M Handa, K Kumar, D Garabadu, PK Kushawaha, R Shukla Therapeutic Delivery 13 (10), 463-476, 2022 | 1 | 2022 |
